DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
T. K. Olsen, C. Dyberg, B. Embaie…·N. Baryawno
This study identifies DHODH as a prognostic marker and therapeutic target in neuroblastoma, showing its inhibition improves survival in preclinical models and suggests combination therapy with temozolomide.